Search
MannKind Corp
MNKDAdd to Watchlist
3.540USD
-0.040-1.12%
Close 09-18 16:00（ET）
1.10BMarket Cap
LossP/E TTM
MannKind Corp (MNKD) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to MannKind Corp in the past month.
Buy
2 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
7.969USD+123.84%
MNKD Analyst Recommendation Trends
In the current month, MNKD has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MNKD average Analyst price target in the last month is 7.969.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
3
3
3
3
3
5
5
5
5
6
6
6
6
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
8
9
9
9
9
9
MNKD Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, MNKD EPS is projected to reach -0.055 in FY2026Q3, following reported EPS of -0.062 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.01
-0.00
-0.00
-0.06
-0.01
Actual
-0.05
-0.05
-0.06
--
--
Surprise
-461.36%
-3669.93%
-4204.20%
--
--
FAQs
What is MannKind Corp's expected revenue for the next quarter?
MannKind Corp's expected revenue is 110.25M.
What is MannKind Corp's price target?
Analysts forecast that MannKind Corp's price target is USD 7.97, with the highest forecast at USD 13.00 and the lowest forecast at USD 4.75.
How have MannKind CorpMNKD's recent earnings per share performed?
The market expectation was USD -0.06, while MannKind CorpMNKD's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for MannKind Corp?
Based on the ratings of MannKind Corp's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.